A hidden translatome in tumors——the coding lncRNAs
作者机构:State Key Laboratory of Molecular OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China
出 版 物:《Science China(Life Sciences)》 (中国科学(生命科学英文版))
年 卷 期:2023年第66卷第12期
页 面:2755-2772页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:supported by the National Key Research and Development Program of China (2021YFF1201300,2022YFE0103600) the National Natural Science Foundation of China (82073094) the CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-014) the Open Issue of State Key Laboratory of Molecular Oncology (SKL-KF-2021-16) the Independent Issue of State Key Laboratory of Molecular Oncology (SKL-2021-16)
主 题:lncRNA translatome peptide tumor
摘 要:Long noncoding RNAs(lncRNAs)have been extensively identified in eukaryotic genomes and have been shown to play critical roles in the development of multiple *** the application and development of ribosome analysis and sequencing technologies,advanced studies have discovered the translation of *** lncRNAs were originally defined as noncoding RNAs,many lncRNAs actually contain small open reading frames that are translated into *** opens a broad area for the functional investigation of ***,we introduce prospective methods and databases for screening lncRNAs with functional *** also summarize the specific lncRNA-encoded proteins and their molecular mechanisms that promote or inhibit ***,the role of lncRNA-encoded peptides/proteins holds promise in cancer research,but some potential challenges remain *** review includes reports on lncRNA-encoded peptides or proteins in cancer,aiming to provide theoretical basis and related references to facilitate the discovery of more functional peptides encoded by lncRNA,and to further develop new anti-cancer therapeutic targets as well as clinical biomarkers of diagnosis and prognosis.